Рет қаралды 1,158
Artificial intelligence in healthcare is finally emerging from being overhyped to showing some practical applications. If it succeeds in the realms of drug discovery, that will be a monumental achievement helping both to speed up and lower the cost for drug development. Learn from experts about where we are in leveraging AI effectively for drug discovery.
Moderator: Frank Vinluan, Senior Biopharma Reporter, MedCity News
Speakers:
Nathan Benaich, PhD, Founder and General Partner, Air Street Capital @nathanbenaich
Chris Gibson, PhD, Co-founder and CEO, Recursion
Najat Khan, PhD, Chief Data Science Officer, Global Head, Strategy and Operations, Janssen Pharmaceutical
Richard Law, PhD, Chief Business Officer, Exscientia